Analysts pick Apple, Micron, Rocket Companies on CNBC
CNBC's 'Halftime Report Final Trades' saw analysts Jim Lebenthal, Malcolm Ethridge, Janine Stichter, and Joshua Brown recommend Micron Technology, Rocket Companies, iShares U.S. Healthcare ETF, and Apple Inc respectively. The picks were based on factors like supply chain disruptions, analyst upgrades, and regulatory approvals for AI services.

*this image is generated using AI for illustrative purposes only.
Market analysts on CNBC's 'Halftime Report Final Trades' named Micron Technology, Rocket Companies, iShares U.S. Healthcare ETF, and Apple Inc as their top picks, citing recent news and analyst actions as primary drivers. The selections come amid significant market movements for these stocks, influenced by regulatory developments and financial upgrades.
Jim Lebenthal, partner and chief market strategist at Cerity Partners, selected Micron Technology, Inc. (NASDAQ: MU). The stock declined almost 6% on Thursday following reports that a U.S. House Committee urged the Trump administration to ban Chinese memory chips, a move that could disrupt established supply chains for memory-related companies.
Malcolm Ethridge, managing partner at Capital Area Planning Group, chose Rocket Companies, Inc. (NYSE: RKT). This recommendation followed an upgrade by Morgan Stanley analyst Jeffrey Adelson, who raised the rating from Equal-Weight to Overweight and increased the price target from $18 to $19.
Janine Stichter recommended the iShares U.S. Healthcare ETF (NYSE: IYH). Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Apple Inc (NASDAQ: AAPL). Apple recently received regulatory approval from China’s cyberspace regulator for its on-device generative artificial intelligence service, Apple Intelligence.
Price Action
The following table details the stock price movements for the mentioned companies on Thursday:
| Company | Price Movement | Closing Price |
|---|---|---|
| Micron Technology | Dipped 5.7% | $853.20 |
| Rocket Companies | Gained 2.1% | $14.90 |
| iShares U.S. Healthcare ETF | Gained 2% | N/A |
| Apple Inc | Rose 1.8% | $333.26 |
How might a potential U.S. ban on Chinese memory chips impact Micron's long-term market share and supply chain stability?
Can Rocket Companies sustain its upward momentum following Morgan Stanley's upgrade given current interest rate trends?
What regulatory or policy shifts could drive the next significant movement in the U.S. Healthcare ETF?
































